Ecolab Delivers Accelerated Sales Growth and Double-Digit EPS Growth; Reported Diluted EPS $1.52; Adjusted Diluted EPS $1.70, +13%; Maintains 2026 Adjusted Diluted EPS Outlook: $8.43 - $8.63, +12% - 15%
FIRST QUARTER HIGHLIGHTS
-
Ecolab delivered another quarter of double-digit EPS growth, driven by continued strong value pricing, accelerated volume growth and solid operating income margin expansion. -
Reported sales
$4.1 billion , +10%. Organic sales accelerated to +4%, led by accelerated growth in Life Sciences, Global High-Tech, Institutional and Specialty. Pest Elimination and Food & Beverage continued to deliver strong growth. - Reported operating income margin 15.3%. Adjusted operating income margin increased 70 bps to 16.7%.
-
Reported diluted EPS
$1.52 , +8%. Adjusted diluted EPS$1.70 , +13%.
MAINTAINS 2026 OUTLOOK
-
2026: Continue to expect adjusted diluted EPS in the
$8.43 to$8.63 range, +12% to 15%, excluding the impact of the pendingCoolIT Systems acquisition.Ecolab expects to quickly offset rising commodity costs through accelerating pricing, record new business wins and improved productivity. -
2Q 2026: Expect adjusted diluted EPS in the
$2.02 to$2.12 range, +7% to 12%. This range reflects a short transition period as benefits from the energy surcharge progressively build to offset higher commodity costs.
|
|
First Quarter Ended |
||||||||||||||||
|
|
Reported |
|
|
|
|
Adjusted |
|
|
|
||||||||
|
(unaudited) |
Public Currency Rates |
|
% |
|
Public Currency Rates |
|
% |
||||||||||
|
(millions, except per share) |
2026 |
|
2025 |
|
Change |
|
2026 |
|
|
2025 |
|
Change |
|||||
|
Net sales |
|
|
|
|
|
|
10 |
% |
|
|
|
|
|
|
|
10 |
% |
|
Operating income |
622.0 |
|
|
555.3 |
|
|
12 |
% |
|
679.7 |
|
|
589.6 |
|
|
15 |
% |
|
Net income attributable to |
432.6 |
|
|
402.5 |
|
|
7 |
% |
|
482.5 |
|
|
427.1 |
|
|
13 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted earnings per share attributable to |
|
|
|
|
|
|
8 |
% |
|
|
|
|
|
|
|
13 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Organic |
|
% |
|
|
|
|
|
|
|
|
|
|||||
|
|
2026 |
|
2025 |
|
Change |
|
|
|
|
|
|
|
|
|
|||
|
Net sales |
|
|
|
|
|
|
4 |
% |
|
|
|
|
|
|
|
|
|
|
Operating income |
664.9 |
|
|
616.2 |
|
|
8 |
% |
|
|
|
|
|
|
|
|
|
CEO Comment
“Accelerated organic sales growth this quarter was led by our growth engines, which collectively strengthened over the prior quarter. Life Sciences accelerated to 11% growth, driven by bioprocessing, which more than doubled its sales during the quarter. Pest Elimination grew 7%, with strong gains from our One Ecolab growth initiative and our new pest intelligence offering. Ecolab Digital and Global High-Tech both grew more than 20%, reflecting strong customer demand for connected, outcome-based solutions. Our core businesses also delivered strong performance as Institutional and Specialty both improved, and Food & Beverage continued to significantly outperform market trends.
“During the quarter, we responded quickly to sharply rising global energy costs driven by geopolitical developments. We took decisive actions across our supply chain, procurement and operations to absorb cost pressures wherever possible. We also announced a global energy surcharge to mitigate the dramatic rise in energy prices. As a result, commodity costs are expected to increase high‑single digits starting in the second quarter, and we expect those costs to remain high through the end of the year. Our priority is, and always will be, being there for our customers and supporting their operations no matter what the environment looks like.
“As we move into the second quarter, we expect a short transition period as we absorb rising commodity costs, while the benefits from the energy surcharge progressively build. Exiting the second quarter, we expect accelerating pricing to cover the dollar impact from higher commodity costs, with gross margin stabilizing in the second half of the year. With this, along with strong new business wins and improved productivity, we expect Ecolab’s performance to strengthen in the second half of the year and are reiterating our expectation to deliver 12-15% adjusted EPS growth in 2026, excluding the impact of the recently announced acquisition of
“The pending acquisition of CoolIT is an important strategic step for
First Quarter 2026 Consolidated Results
Ecolab’s first quarter reported sales increased 10%. Organic sales growth accelerated to 4% when compared to the prior year. Ecolab Digital sales increased 24% to
First quarter 2026 reported operating income increased 12% including the impact of special gains and charges. Adjusted operating income increased 15%, as accelerated sales growth and improved productivity more than offset higher commodity costs and growth-oriented investments in the business.
Reported other income in the first quarter of 2026 decreased
The reported income tax rate for the first quarter of 2026 was 21.8% compared with the reported rate of 20.3% in the first quarter of 2025. Excluding special gains and charges and discrete tax items, the adjusted tax rate for the first quarter of 2026 was 21.0% compared with the adjusted tax rate of 20.8% in the first quarter of 2025.
Reported net income increased 7% versus the prior year. Excluding the impact of special gains and charges and discrete tax items, adjusted net income increased 13% versus the prior year.
Reported diluted earnings per share increased 8% versus the prior year. Adjusted diluted earnings per share increased 13% when compared against the first quarter of 2025.
First Quarter 2026 Segment Review
|
Global Water |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(unaudited) |
|
First Quarter Ended |
|
|
|
|
Organic |
|||||
|
(millions) |
|
2026 |
|
2025 |
|
% Change |
|
% Change |
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed currency |
|
|
|
|
|
|
|
|
|
|
|
|
|
Sales |
|
|
|
|
|
|
|
7 |
% |
|
2 |
% |
|
Operating income |
|
297.8 |
|
|
278.7 |
|
|
7 |
% |
|
0 |
% |
|
Operating income margin |
|
14.6 |
% |
|
14.7 |
% |
|
|
|
|
|
|
|
Organic operating income margin |
|
14.3 |
% |
|
14.7 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Public currency |
|
|
|
|
|
|
|
|
|
|
|
|
|
Sales |
|
|
|
|
|
|
|
12 |
% |
|
|
|
|
Operating income |
|
299.3 |
|
|
264.1 |
|
|
13 |
% |
|
|
|
|
|
||||||||||||
|
The Global Water segment includes Heavy Water, |
||||||||||||
Fixed currency sales increased 7%, driven by a 5% benefit from the
|
Global Institutional & Specialty |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(unaudited) |
|
First Quarter Ended |
|
|
|
|
Organic |
|||||
|
(millions) |
|
2026 |
|
2025 |
|
% Change |
|
% Change |
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed currency |
|
|
|
|
|
|
|
|
|
|
|
|
|
Sales |
|
|
|
|
|
|
|
4 |
% |
|
4 |
% |
|
Operating income |
|
347.5 |
|
|
308.4 |
|
|
13 |
% |
|
13 |
% |
|
Operating income margin |
|
23.0 |
% |
|
21.2 |
% |
|
|
|
|
|
|
|
Organic operating income margin |
|
23.0 |
% |
|
21.2 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Public currency |
|
|
|
|
|
|
|
|
|
|
|
|
|
Sales |
|
|
|
|
|
|
|
7 |
% |
|
|
|
|
Operating income |
|
348.2 |
|
|
301.2 |
|
|
16 |
% |
|
|
|
Fixed currency and organic sales growth both improved to 4%. Institutional’s improved performance was driven by good growth with hospitality customers. Specialty’s sales grew high-single digits, with accelerated growth driven by robust new business wins and continued value pricing. Organic operating income increased 13%, as strong sales growth more than offset higher commodity costs.
|
Global Pest Elimination |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(unaudited) |
|
First Quarter Ended |
|
|
|
|
Organic |
|||||
|
(millions) |
|
2026 |
|
2025 |
|
% Change |
|
% Change |
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed currency |
|
|
|
|
|
|
|
|
|
|
|
|
|
Sales |
|
|
|
|
|
|
|
8 |
% |
|
7 |
% |
|
Operating income |
|
51.7 |
|
|
47.7 |
|
|
8 |
% |
|
10 |
% |
|
Operating income margin |
|
16.7 |
% |
|
16.6 |
% |
|
|
|
|
|
|
|
Organic operating income margin |
|
17.0 |
% |
|
16.6 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Public currency |
|
|
|
|
|
|
|
|
|
|
|
|
|
Sales |
|
|
|
|
|
|
|
11 |
% |
|
|
|
|
Operating income |
|
51.9 |
|
|
46.5 |
|
|
12 |
% |
|
|
|
Fixed currency sales increased 8%, reflecting 7% organic growth and a 1% benefit from attractive, targeted acquisitions in
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(unaudited) |
|
First Quarter Ended |
|
|
|
|
Organic |
|||||
|
(millions) |
|
2026 |
|
2025 |
|
% Change |
|
% Change |
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed currency |
|
|
|
|
|
|
|
|
|
|
|
|
|
Sales |
|
|
|
|
|
|
|
11 |
% |
|
11 |
% |
|
Operating income |
|
37.5 |
|
|
31.0 |
|
|
21 |
% |
|
21 |
% |
|
Operating income margin |
|
18.7 |
% |
|
17.1 |
% |
|
|
|
|
|
|
|
Organic operating income margin |
|
18.7 |
% |
|
17.1 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Public currency |
|
|
|
|
|
|
|
|
|
|
|
|
|
Sales |
|
|
|
|
|
|
|
18 |
% |
|
|
|
|
Operating income |
|
37.7 |
|
|
26.6 |
|
|
42 |
% |
|
|
|
Fixed currency and organic sales growth both accelerated to 11%. This strong growth was driven by bioprocessing, which more than doubled its sales during the quarter. This, along with robust growth in pharmaceutical & personal care, overcame temporary capacity constraints within Life Sciences’ industrial water purification business. Organic operating income increased 21%, as strong sales growth and lower supply chain costs more than offset unfavorable mix and growth-oriented investments in the business. Life Sciences’ current upper-teens organic operating income margin reflects strong underlying profitability and continued investments in breakthrough innovation, global capabilities, and capacity to unlock this very attractive, long-term growth opportunity.
|
Corporate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(unaudited) |
|
First Quarter Ended |
||||
|
(millions) |
|
2026 |
|
2025 |
||
|
|
|
|
|
|
|
|
|
Public currency |
|
|
|
|
|
|
|
Corporate operating expense |
|
|
|
|
|
|
|
Transformational acquisition amortization |
|
|
|
|
|
|
|
Special (gains) and charges |
|
57.7 |
|
|
34.3 |
|
|
Total Corporate operating expense (income) |
|
|
|
|
|
|
First quarter of 2026 corporate segment includes:
-
amortization expense of
$28 million related to the Nalco merger intangible assets,$22 million related to Purolite acquisition intangible assets and$8 million related to theOvivo Electronics acquisition intangible assets -
special gains and charges were a net charge of
$58 million , primarily related to One Ecolab and acquisition and integration costs for theOvivo Electronics and pendingCoolIT Systems acquisitions
Special gains and charges for the first quarter of 2025 impacting operating expense were a net charge of
Business Outlook
2026
Long-term growth trends in water, hygiene, infection prevention, and digital technologies continue to fuel resilient demand for Ecolab’s innovative technologies and services. Strong momentum in Ecolab’s growth engines, which include Global High-Tech, Life Sciences, Pest Elimination and Ecolab Digital, is expected to continue to strengthen Ecolab’s overall performance. Ecolab’s investments in these areas position the company well to capitalize on these attractive long-term high-growth, high-margin opportunities.
In the near-term, the global operating environment remains unpredictable, including constantly evolving geopolitics and international trade policy, which are resulting in rising commodity costs and emerging challenges in the
With progressively accelerating pricing and the acquisition of
In total,
The company currently anticipates quantifiable special charges in 2026 to be approximately
2026 – Second Quarter
The company currently expects quantifiable special charges in the second quarter of 2026 to be approximately
About
A trusted partner for millions of customers,
Cautionary Statements Regarding Forward-Looking Information
This news release contains certain statements relating to future events and our intentions, beliefs, expectations and predictions for the future which are forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Words or phrases such as “will likely result,” “are expected to,” “will continue,” “is anticipated,” “we believe,” “we expect,” “estimate,” “project,” “may,” “will,” “intend,” “plan,” “believe,” “target,” “forecast” (including the negative or variations thereof) or similar terminology used in connection with any discussion of future plans, actions or events generally identify forward-looking statements. These forward-looking statements include, but are not limited to, statements regarding macroeconomic conditions and our financial and business performance and prospects, including sales, earnings, special gains and charges, raw material costs, margins, pricing, currency translation, productivity, investments, acquisitions and new business. These statements are based on the current expectations of management of the company. There are a number of risks and uncertainties that could cause actual results to differ materially from the forward-looking statements included in this news release. In particular, the ultimate results of any restructuring initiative depend on a number of factors, including the development of final plans, the impact of local regulatory requirements regarding employee terminations, the time necessary to develop and implement the restructuring initiatives and the level of success achieved through such actions in improving competitiveness, efficiency and effectiveness.
Additional risks and uncertainties that may affect operating results and business performance are set forth under Item 1A of our most recent Form 10-K, and our other public filings with the Securities and Exchange Commission (the "
Non-GAAP Financial Information
This news release and certain of the accompanying tables include financial measures that have not been calculated in accordance with accounting principles generally accepted in the
These non-GAAP financial measures may include:
- fixed currency sales
- organic sales
- adjusted cost of sales
- adjusted gross profit
- adjusted gross margin
- fixed currency operating income
- fixed currency operating income margin
- adjusted operating income
- adjusted fixed currency operating income
- adjusted fixed currency operating income margin
- organic operating income
- organic operating income margin
- adjusted tax rate
-
adjusted net income attributable to
Ecolab - adjusted diluted earnings per share
- free cash flow
We provide these measures as additional information regarding our operating results. We use these non-GAAP measures internally to evaluate our performance and in making financial and operational decisions, including with respect to incentive compensation. We believe that our presentation of these measures provides investors with greater transparency with respect to our results of operations and that these measures are useful for period-to-period comparison of results.
Our non-GAAP financial measures for adjusted cost of sales, adjusted gross margin, adjusted gross profit and adjusted operating income exclude the impact of special (gains) and charges and our non-GAAP financial measures for adjusted tax rate, adjusted net income attributable to
We evaluate the performance of our international operations based on fixed currency rates of foreign exchange, which eliminate the translation impact of exchange rate fluctuations on our international results. Fixed currency amounts included in this release are based on translation into
Our reportable segments do not include the impact of intangible asset amortization from the Nalco, Purolite and
Our non-GAAP financial measures for organic sales, organic operating income and organic operating income margin are at fixed currency and exclude the impact of special (gains) and charges where applicable, the results of our acquired businesses from the first twelve months post acquisition and the results of divested businesses from the twelve months prior to divestiture.
We define free cash flow as net cash provided by operating activities less cash outlays for capital expenditures. It should not be inferred that the entire free cash flow amount is available for discretionary expenditures. It should not be considered a substitute for income or cash flow data prepared in accordance with
These non-GAAP financial measures are not in accordance with, or an alternative to, GAAP and may be different from non-GAAP measures used by other companies. Investors should not rely on any single financial measure when evaluating our business. We recommend that investors view these measures in conjunction with the GAAP measures included in this news release. Reconciliations of our non-GAAP measures are included in the following "Supplemental Non-GAAP Reconciliations" and “Supplemental Diluted Earnings per Share Information” tables included in this news release.
We do not provide reconciliations for non-GAAP estimates on a forward-looking basis (including those contained in this news release) when we are unable to provide a meaningful or accurate calculation or estimation of reconciling items and the information is not available without unreasonable effort. This is due to the inherent difficulty of forecasting the timing and amount of various items that have not yet occurred, are out of our control and/or cannot be reasonably predicted, and that would impact reported earnings per share and the reported tax rate, the most directly comparable forward-looking GAAP financial measures to adjusted earnings per share and the adjusted tax rate. For the same reasons, we are unable to address the probable significance of the unavailable information.
(ECL-E)
|
CONSOLIDATED STATEMENTS OF INCOME (unaudited) |
||||||||||
|
|
||||||||||
|
|
|
First Quarter Ended |
|
|
||||||
|
|
|
|
|
% |
||||||
|
(millions, except per share) |
|
2026 |
|
|
2025 |
|
|
Change |
||
|
|
|
|
|
|
|
|
|
|||
|
Product and equipment sales |
|
|
|
|
|
|
|
|
|
|
|
Service and lease sales |
|
891.5 |
|
|
793.1 |
|
|
|
|
|
|
Net sales |
|
4,066.1 |
|
|
3,695.0 |
|
|
10 |
|
% |
|
Product and equipment cost of sales |
|
1,786.2 |
|
|
1,605.4 |
|
|
|
|
|
|
Service and lease cost of sales |
|
509.1 |
|
|
454.8 |
|
|
|
|
|
|
Cost of sales (1) |
|
2,295.3 |
|
|
2,060.2 |
|
|
11 |
|
% |
|
Selling, general and administrative expenses |
|
1,102.4 |
|
|
1,050.0 |
|
|
5 |
|
% |
|
Special (gains) and charges (1) |
|
46.4 |
|
|
29.5 |
|
|
|
|
|
|
Operating income |
|
622.0 |
|
|
555.3 |
|
|
12 |
|
% |
|
Other (income) expense |
|
(8.8 |
) |
|
(13.0 |
) |
|
(32 |
) |
% |
|
Interest expense, net |
|
72.7 |
|
|
58.3 |
|
|
25 |
|
% |
|
Income before income taxes |
|
558.1 |
|
|
510.0 |
|
|
9 |
|
% |
|
Provision for income taxes |
|
121.5 |
|
|
103.5 |
|
|
17 |
|
% |
|
Net income including noncontrolling interest |
|
436.6 |
|
|
406.5 |
|
|
7 |
|
% |
|
Net income attributable to noncontrolling interest |
|
4.0 |
|
|
4.0 |
|
|
|
|
|
|
Net income attributable to |
|
|
|
|
|
|
|
7 |
|
% |
|
|
|
|
|
|
|
|
|
|||
|
Earnings attributable to |
|
|
|
|
|
|||||
|
Basic |
|
|
|
|
|
|
|
8 |
|
% |
|
Diluted |
|
|
|
|
|
|
|
8 |
|
% |
|
|
|
|
|
|
|
|
|
|||
|
Weighted-average common shares outstanding |
|
|
|
|
|
|||||
|
Basic |
|
282.0 |
|
|
283.4 |
|
|
0 |
|
% |
|
Diluted |
|
283.7 |
|
|
285.3 |
|
|
(1 |
) |
% |
|
|
|
|
|
|
|
|
|
|||
|
(1) Cost of sales and Special (gains) and charges in the Consolidated Statement of Income above include the following: |
||||||||||
|
|
|
|
|
|
|
|
|
|||
|
|
|
First Quarter Ended |
|
|
||||||
|
|
|
|
|
|
|
|||||
|
(millions) |
|
2026 |
|
|
2025 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
Cost of sales |
|
|
|
|
|
|
|
|||
|
One |
|
|
|
|
|
|
|
|
|
|
|
Other restructuring |
|
9.7 |
|
|
- |
|
|
|
|
|
|
Subtotal (a) |
|
11.3 |
|
|
4.8 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
Special (gains) and charges |
|
|
|
|
|
|
|
|||
|
One |
|
31.4 |
|
|
39.4 |
|
|
|
|
|
|
Acquisition and integration activities |
|
14.1 |
|
|
1.5 |
|
|
|
|
|
|
Sale of global surgical solutions business |
|
- |
|
|
1.6 |
|
|
|
|
|
|
Other |
|
0.9 |
|
|
(13.0 |
) |
|
|
|
|
|
Subtotal |
|
46.4 |
|
|
29.5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
Total special (gains) and charges |
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
(a) Special charges of |
||||||||||
|
REPORTABLE SEGMENT INFORMATION (unaudited) |
||||||||||||||||||
|
|
||||||||||||||||||
|
|
|
First Quarter Ended |
||||||||||||||||
|
|
|
Fixed Currency Rates |
|
Public Currency Rates |
||||||||||||||
|
|
|
|
|
|
|
% |
|
|
|
|
|
% |
||||||
|
(millions) |
|
2026 |
|
|
2025 |
|
|
Change |
|
2026 |
|
|
2025 |
|
|
Change |
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Global Water |
|
|
|
|
|
|
|
7 |
% |
|
|
|
|
|
|
|
12 |
% |
|
Global Institutional & Specialty |
|
1,507.7 |
|
|
1,454.8 |
|
|
4 |
% |
|
1,511.4 |
|
|
1,418.0 |
|
|
7 |
% |
|
Global Pest Elimination |
|
310.1 |
|
|
287.4 |
|
|
8 |
% |
|
310.8 |
|
|
280.6 |
|
|
11 |
% |
|
|
|
200.9 |
|
|
181.4 |
|
|
11 |
% |
|
200.9 |
|
|
170.0 |
|
|
18 |
% |
|
Subtotal at fixed currency rates |
|
4,053.9 |
|
|
3,823.1 |
|
|
6 |
% |
|
4,066.1 |
|
|
3,695.0 |
|
|
10 |
% |
|
Currency impact |
|
12.2 |
|
|
(128.1 |
) |
|
* |
|
|
- |
|
|
- |
|
|
* |
|
|
Consolidated reported GAAP net sales |
|
|
|
|
|
|
|
10 |
% |
|
|
|
|
|
|
|
10 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Operating Income (loss) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Global Water |
|
|
|
|
|
|
|
7 |
% |
|
|
|
|
|
|
|
13 |
% |
|
Global Institutional & Specialty |
|
347.5 |
|
|
308.4 |
|
|
13 |
% |
|
348.2 |
|
|
301.2 |
|
|
16 |
% |
|
Global Pest Elimination |
|
51.7 |
|
|
47.7 |
|
|
8 |
% |
|
51.9 |
|
|
46.5 |
|
|
12 |
% |
|
|
|
37.5 |
|
|
31.0 |
|
|
21 |
% |
|
37.7 |
|
|
26.6 |
|
|
42 |
% |
|
Corporate |
|
(114.8 |
) |
|
(83.5 |
) |
|
* |
|
|
(115.1 |
) |
|
(83.1 |
) |
|
* |
|
|
Subtotal at fixed currency rates |
|
619.7 |
|
|
582.3 |
|
|
6 |
% |
|
622.0 |
|
|
555.3 |
|
|
12 |
% |
|
Currency impact |
|
2.3 |
|
|
(27.0 |
) |
|
* |
|
|
- |
|
|
- |
|
|
* |
|
|
Consolidated reported GAAP operating income |
|
|
|
|
|
|
|
12 |
% |
|
|
|
|
|
|
|
12 |
% |
|
|
||||||||||||||||||
|
* Not meaningful. |
||||||||||||||||||
|
|
||||||||||||||||||
|
As shown in the “Fixed Currency Rates” tables above, we evaluate the performance of our international operations based on fixed currency exchange rates, which eliminate the impact of exchange rate fluctuations on our international operations. Amounts shown in the “Public Currency Rates” tables above reflect amounts translated at actual public average rates of exchange prevailing during the corresponding period and are provided for informational purposes. The difference between the fixed currency exchange rates and the public currency exchange rates is reported as “Currency impact” in the “Fixed Currency Rates” tables above. |
||||||||||||||||||
|
|
||||||||||||||||||
|
The Corporate segment includes amortization from the Nalco, Purolite and |
||||||||||||||||||
|
CONSOLIDATED BALANCE SHEETS (unaudited) |
||||||||||||
|
|
||||||||||||
|
|
|
|
|
|
||||||||
|
(millions) |
2026 |
|
|
2025 |
|
2025 |
|
|||||
|
Assets |
|
|
|
|
|
|
|
|
||||
|
Current assets |
|
|
|
|
|
|
|
|
||||
|
Cash and cash equivalents |
|
|
|
|
|
|
|
|
|
|
|
|
|
Accounts receivable, net |
3,280.2 |
|
|
|
3,249.4 |
|
|
|
2,857.1 |
|
|
|
|
Inventories |
1,572.0 |
|
|
|
1,490.4 |
|
|
|
1,547.2 |
|
|
|
|
Other current assets |
670.7 |
|
|
|
569.6 |
|
|
|
514.2 |
|
|
|
|
Total current assets |
6,042.7 |
|
|
|
5,955.6 |
|
|
|
6,081.1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Property, plant and equipment, net |
4,397.2 |
|
|
|
4,276.6 |
|
|
|
3,775.8 |
|
|
|
|
|
9,438.7 |
|
|
|
9,227.0 |
|
|
|
7,864.5 |
|
|
|
|
Other intangible assets, net |
3,524.2 |
|
|
|
3,688.5 |
|
|
|
3,228.7 |
|
|
|
|
Operating lease assets |
775.1 |
|
|
|
765.9 |
|
|
|
750.7 |
|
|
|
|
Other assets |
862.7 |
|
|
|
782.7 |
|
|
|
665.6 |
|
|
|
|
Total assets |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Liabilities and Equity |
|
|
|
|
|
|
|
|
||||
|
Current liabilities |
|
|
|
|
|
|
|
|
||||
|
Short-term debt |
|
|
|
|
|
|
|
|
|
|
|
|
|
Accounts payable |
2,054.8 |
|
|
|
2,071.0 |
|
|
|
1,765.6 |
|
|
|
|
Compensation and benefits |
571.4 |
|
|
|
721.5 |
|
|
|
540.1 |
|
|
|
|
Income taxes |
127.4 |
|
|
|
134.3 |
|
|
|
178.5 |
|
|
|
|
Other current liabilities |
1,768.9 |
|
|
|
1,737.5 |
|
|
|
1,510.8 |
|
|
|
|
Total current liabilities |
6,095.7 |
|
|
|
5,534.7 |
|
|
|
4,609.2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Long-term debt |
6,922.5 |
|
|
|
7,365.9 |
|
|
|
6,997.6 |
|
|
|
|
Pension and postretirement benefits |
547.6 |
|
|
|
546.1 |
|
|
|
590.2 |
|
|
|
|
Deferred income taxes |
389.5 |
|
|
|
329.9 |
|
|
|
249.4 |
|
|
|
|
Operating lease liabilities |
603.5 |
|
|
|
596.5 |
|
|
|
598.8 |
|
|
|
|
Other liabilities |
449.8 |
|
|
|
518.7 |
|
|
|
417.5 |
|
|
|
|
Total liabilities |
15,008.6 |
|
|
|
14,891.8 |
|
|
|
13,462.7 |
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Equity |
|
|
|
|
|
|
|
|
||||
|
Common stock |
370.2 |
|
|
|
369.4 |
|
|
|
368.6 |
|
|
|
|
Additional paid-in capital |
7,643.7 |
|
|
|
7,521.3 |
|
|
|
7,298.2 |
|
|
|
|
Retained earnings |
13,060.5 |
|
|
|
12,834.0 |
|
|
|
11,735.2 |
|
|
|
|
Accumulated other comprehensive loss |
(1,626.1 |
) |
|
|
(1,874.3 |
) |
|
|
(2,064.2 |
) |
|
|
|
|
(9,444.4 |
) |
|
|
(9,079.6 |
) |
|
|
(8,462.0 |
) |
|
|
|
Total |
10,003.9 |
|
|
|
9,770.8 |
|
|
|
8,875.8 |
|
|
|
|
Noncontrolling interest |
28.1 |
|
|
|
33.7 |
|
|
|
27.9 |
|
|
|
|
Total equity |
10,032.0 |
|
|
|
9,804.5 |
|
|
|
8,903.7 |
|
|
|
|
Total liabilities and equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
SUPPLEMENTAL NON-GAAP RECONCILIATIONS (unaudited) |
||||||||
|
|
||||||||
|
|
|
First Quarter Ended |
|
|||||
|
|
|
|
|
|||||
|
(millions, except percent and per share) |
|
2026 |
|
|
2025 |
|
||
|
|
|
|
|
|
|
|
|
|
|
Net sales |
|
|
|
|
|
|
|
|
|
Reported GAAP net sales |
|
|
|
|
|
|
|
|
|
Effect of foreign currency translation |
|
(12.2 |
) |
|
|
128.1 |
|
|
|
Non-GAAP fixed currency sales |
|
4,053.9 |
|
|
|
3,823.1 |
|
|
|
Effect of acquisitions and divestitures |
|
(96.6 |
) |
|
|
- |
|
|
|
Non-GAAP organic sales |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost of sales |
|
|
|
|
|
|
|
|
|
Reported GAAP cost of sales |
|
|
|
|
|
|
|
|
|
Special (gains) and charges |
|
11.3 |
|
|
|
4.8 |
|
|
|
Non-GAAP adjusted cost of sales |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross profit |
|
|
|
|
|
|
|
|
|
Reported GAAP gross profit |
|
|
|
|
|
|
|
|
|
Special (gains) and charges |
|
11.3 |
|
|
|
4.8 |
|
|
|
Non-GAAP adjusted gross profit |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross margin |
|
|
|
|
|
|
|
|
|
Reported GAAP gross margin |
|
43.6 |
|
% |
|
44.2 |
% |
|
|
Non-GAAP adjusted gross margin |
|
43.8 |
|
% |
|
44.4 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
Operating income |
|
|
|
|
|
|
|
|
|
Reported GAAP operating income |
|
|
|
|
|
|
|
|
|
Special (gains) and charges at public currency rates |
|
57.7 |
|
|
|
34.3 |
|
|
|
Non-GAAP adjusted operating income |
|
679.7 |
|
|
|
589.6 |
|
|
|
Effect of foreign currency translation |
|
(3.4 |
) |
|
|
26.6 |
|
|
|
Non-GAAP adjusted fixed currency operating income |
|
676.3 |
|
|
|
616.2 |
|
|
|
Effect of acquisitions and divestitures |
|
(11.4 |
) |
|
|
- |
|
|
|
Non-GAAP organic operating income |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating income margin |
|
|
|
|
|
|
|
|
|
Reported GAAP operating income margin |
|
15.3 |
|
% |
|
15.0 |
% |
|
|
Non-GAAP adjusted operating income margin |
|
16.7 |
|
% |
|
16.0 |
% |
|
|
Non-GAAP organic operating income margin |
|
16.8 |
|
% |
|
16.1 |
% |
|
|
SUPPLEMENTAL NON-GAAP RECONCILIATIONS (unaudited) |
|||||||||
|
|
|||||||||
|
|
|
First Quarter Ended |
|
||||||
|
|
|
|
|
||||||
|
(millions, except percent and per share) |
|
2026 |
|
|
2025 |
|
|
||
|
Net Income attributable to |
|
|
|
|
|
|
|
||
|
Reported GAAP net income attributable to |
|
|
|
|
|
|
|
|
|
|
Special (gains) and charges, after tax |
|
45.5 |
|
|
|
25.1 |
|
|
|
|
Discrete tax net expense (benefit) |
|
4.4 |
|
|
|
(0.5 |
) |
|
|
|
Non-GAAP adjusted net income attributable to |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
|
Diluted EPS attributable to |
|
|
|
|
|
|
|
||
|
Reported GAAP diluted EPS |
|
|
|
|
|
|
|
|
|
|
Special (gains) and charges, after tax |
|
0.16 |
|
|
|
0.09 |
|
|
|
|
Discrete tax net expense (benefit) |
|
0.02 |
|
|
|
0.00 |
|
|
|
|
Non-GAAP adjusted diluted EPS |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
|
Provision for Income Taxes |
|
|
|
|
|
|
|
||
|
Reported GAAP tax rate |
|
21.8 |
|
% |
|
20.3 |
|
% |
|
|
Special gains and charges |
|
(0.1 |
) |
|
|
0.4 |
|
|
|
|
Discrete tax items |
|
(0.7 |
) |
|
|
0.1 |
|
|
|
|
Non-GAAP adjusted tax rate |
|
21.0 |
|
% |
|
20.8 |
|
% |
|
|
SUPPLEMENTAL NON-GAAP RECONCILIATIONS (unaudited) |
|||||||||||||||||
|
|
|||||||||||||||||
|
|
|
First Quarter Ended |
|||||||||||||||
|
|
|
2026 |
|
|
|
|
2025 |
|
|
||||||||
|
(millions) |
|
Fixed Currency |
|
Impact of
|
|
Organic |
|
Fixed Currency |
|
Impact of
|
|
Organic |
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Global Water |
|
|
|
|
( |
) |
|
|
|
|
|
|
|
$- |
|
|
|
|
Global Institutional & Specialty |
|
1,507.7 |
|
|
- |
|
|
1,507.7 |
|
|
1,454.8 |
|
|
- |
|
1,454.8 |
|
|
Global Pest Elimination |
|
310.1 |
|
|
(1.6 |
) |
|
308.5 |
|
|
287.4 |
|
|
- |
|
287.4 |
|
|
|
|
200.9 |
|
|
- |
|
|
200.9 |
|
|
181.4 |
|
|
- |
|
181.4 |
|
|
Subtotal at fixed currency rates |
|
4,053.9 |
|
|
(96.6 |
) |
|
3,957.3 |
|
|
3,823.1 |
|
|
- |
|
3,823.1 |
|
|
Currency impact |
|
12.2 |
|
|
|
|
|
|
(128.1 |
) |
|
|
|
|
|||
|
Consolidated reported GAAP net sales |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Operating Income (loss) |
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Global Water |
|
|
|
|
( |
) |
|
|
|
|
|
|
|
$- |
|
|
|
|
Global Institutional & Specialty |
|
347.5 |
|
|
- |
|
|
347.5 |
|
|
308.4 |
|
|
- |
|
308.4 |
|
|
Global Pest Elimination |
|
51.7 |
|
|
0.6 |
|
|
52.3 |
|
|
47.7 |
|
|
- |
|
47.7 |
|
|
|
|
37.5 |
|
|
- |
|
|
37.5 |
|
|
31.0 |
|
|
- |
|
31.0 |
|
|
Corporate |
|
(58.2 |
) |
|
8.4 |
|
|
(49.8 |
) |
|
(49.6 |
) |
|
- |
|
(49.6 |
) |
|
Subtotal at fixed currency rates |
|
676.3 |
|
|
(11.4 |
) |
|
664.9 |
|
|
616.2 |
|
|
- |
|
616.2 |
|
|
Special (gains) and charges at fixed currency rates |
|
56.6 |
|
|
|
|
|
|
33.9 |
|
|
|
|
|
|||
|
Reported OI at fixed currency rates |
|
619.7 |
|
|
|
|
|
|
582.3 |
|
|
|
|
|
|||
|
Currency impact |
|
2.3 |
|
|
|
|
|
|
(27.0 |
) |
|
|
|
|
|||
|
Consolidated reported GAAP operating income |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
SUPPLEMENTAL DILUTED EARNINGS PER SHARE INFORMATION (unaudited)
The table below provides a reconciliation of diluted earnings per share, as reported, to the non-GAAP measure of adjusted diluted earnings per share. |
|||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
|
First |
|
Second |
|
Six |
|
Third |
|
Nine |
|
Fourth |
|
|
|
||||||
|
|
|
Quarter |
|
Quarter |
|
Months |
|
Quarter |
|
Months |
|
Quarter |
|
Year |
|
||||||
|
|
|
Ended |
|
Ended |
|
Ended |
|
Ended |
|
Ended |
|
Ended |
|
Ended |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
|
2025 |
|
2025 |
|
2025 |
|
2025 |
|
2025 |
|
2025 |
|
2025 |
|
||||||
|
Diluted earnings per share, as reported ( |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjustments: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
Special (gains) and charges (1) |
|
0.09 |
|
0.07 |
|
|
0.16 |
|
|
0.08 |
|
|
0.24 |
|
|
0.21 |
|
|
0.45 |
|
|
|
Discrete tax expense (benefits) (2) |
|
0.00 |
|
(0.02 |
) |
|
(0.02 |
) |
|
(0.06 |
) |
|
(0.08 |
) |
|
(0.12 |
) |
|
(0.21 |
) |
|
|
Impact of |
|
0.00 |
|
0.00 |
|
|
0.00 |
|
|
0.00 |
|
|
0.00 |
|
|
0.01 |
|
|
0.01 |
|
|
|
Adjusted diluted earnings per share (Non-GAAP) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
|
First |
|
Second |
|
Six |
|
Third |
|
Nine |
|
Fourth |
|
|
|
||||||
|
|
|
Quarter |
|
Quarter |
|
Months |
|
Quarter |
|
Months |
|
Quarter |
|
Year |
|
||||||
|
|
|
Ended |
|
Ended |
|
Ended |
|
Ended |
|
Ended |
|
Ended |
|
Ended |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
|
2026 |
|
2026 |
|
2026 |
|
2026 |
|
2026 |
|
2026 |
|
2026 |
|
||||||
|
Diluted earnings per share, as reported ( |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
Adjustments: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
Special (gains) and charges (3) |
|
0.16 |
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
Discrete tax expense (benefits) (4) |
|
0.02 |
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
Adjusted diluted earnings per share (Non-GAAP) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
Per share amounts do not necessarily sum due to changes in shares outstanding and rounding. |
|||||||||||||||||||||
|
|
|||||||||||||||||||||
|
(1) Special (gains) and charges for 2025 includes charges of |
|||||||||||||||||||||
|
|
|||||||||||||||||||||
|
(2) Discrete tax expenses (benefits) for 2025 includes |
|||||||||||||||||||||
|
|
|||||||||||||||||||||
|
(3) Special (gains) and charges for 2026 includes |
|||||||||||||||||||||
|
|
|||||||||||||||||||||
|
(4) Discrete tax expenses (benefits) for 2026 includes |
|||||||||||||||||||||
View source version on businesswire.com: https://www.businesswire.com/news/home/20260427843380/en/
Investor Contact:
Media Contact:
Source: